Aug 1, 2005

Adobe Discusses Its Life Science Strategy

Source: BioIT World
Written By Salvatore Salamone

With most pharmaceutical companies counted as customers, and electronic submissions to the FDA requiring documents to be in PDF format, Adobe is no stranger to the life sciences.

But the company has been reinforcing its ties to the industry with a concerted life science effort that has a dedicated staff of industry experts.

“The vertical focus on the life sciences is new, but [Adobe’s] work in the area is not new,” says Melonie Warfel, director of Adobe Life Sciences.

The life science effort at Adobe is an umbrella program that covers pharmaceutical, biotech, and medical device companies. Part of the effort is ensuring that documents meet FDA submission and other regulatory requirements. Within the pharmaceutical industry, the program targets a wide range of application areas, including R&D, clinical development, regulatory affairs, manufacturing, and marketing and sales.

Warfel notes that many of the business trends and business priorities that the Life Sciences group deals with are not new. “Our customers say they need to maintain their competitive advantage, comply with regulatory requirements, and protect their intellectual property,” says Warfel.

What is new is the amount of information that is being collected in life science organizations today. Adobe sees its strength in helping companies gather, present, and safely share this information.

Read entire article

Comments are closed.